Skip to Main Content

Author Details

Peter Merrill
Duke Clinical Research Institute, Duke University School of Medicine
2010
18
10
PMIDPaper TitleJournal TitlePublished Year
36700460Sex differences in the complications, care and clinical outcomes of patients with type 2 diabetes in the Exenatide Study of Cardiovascular Event Lowering (EXSCEL).Diabetes Obes Metab2023
36269028Rationale and design of a multicenter randomized clinical trial of vestibulodynia: understanding pathophysiology and determining appropriate treatments (vestibulodynia: UPDATe).Ann Med2022
35660539Design and rationale of GUARDD-US: A pragmatic, randomized trial of genetic testing for APOL1 and pharmacogenomic predictors of antihypertensive efficacy in patients with hypertension.Contemp Clin Trials2022
32938772Premature permanent discontinuation of apixaban or warfarin in patients with atrial fibrillation.Heart2021
32590958Rationale and design of "Hearts & Parks": study protocol for a pragmatic randomized clinical trial of an integrated clinic-community intervention to treat pediatric obesity.BMC Pediatr2020
31010875Changes in Serum Calcitonin Concentrations, Incidence of Medullary Thyroid Carcinoma, and Impact of Routine Calcitonin Concentration Monitoring in the EXenatide Study of Cardiovascular Event Lowering (EXSCEL).Diabetes Care2019
29221659Cardiovascular outcomes with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a meta-analysis.Lancet Diabetes Endocrinol2018
30371301Effect of Once-Weekly Exenatide on Clinical Outcomes According to Baseline Risk in Patients With Type 2 Diabetes Mellitus: Insights From the EXSCEL Trial.J Am Heart Assoc2018
29447783Representation of black patients in randomized clinical trials of heart failure with reduced ejection fraction.Am Heart J2018
29385429Antithrombotic therapy use and clinical outcomes following thrombo-embolic events in patients with atrial fibrillation: insights from ARISTOTLE.Eur Heart J Cardiovasc Pharmacother2018
29649631Simultaneous Risk Factor Control Using Telehealth to slOw Progression of Diabetic Kidney Disease (STOP-DKD) study: Protocol and baseline characteristics of a randomized controlled trial.Contemp Clin Trials2018
28595791Association between trace elements in the environment and stroke risk: The reasons for geographic and racial differences in stroke (REGARDS) study.J Trace Elem Med Biol2017
28194628Association between CK-MB Area Under the Curve and Tranexamic Acid Utilization in Patients Undergoing Coronary Artery Bypass Surgery.J Thromb Thrombolysis2017
28359513Exercise Training in Patients With Chronic Heart Failure and Atrial Fibrillation.J Am Coll Cardiol2017
26573840Dichotomizing partial compliance and increased participant burden in factorial designs: the performance of four noncompliance methods.Trials2015
24522444Intake of trans fat and incidence of stroke in the REasons for Geographic And Racial Differences in Stroke (REGARDS) cohort.Am J Clin Nutr2014
23553155Intake of trans fat and all-cause mortality in the Reasons for Geographical and Racial Differences in Stroke (REGARDS) cohort.Am J Clin Nutr2013
20190000Racial disparities in awareness and treatment of atrial fibrillation: the REasons for Geographic and Racial Differences in Stroke (REGARDS) study.Stroke2010
  • 1 - 18 of 18

Recommended Authors

Kaiser Permanente Southern California
Career Start Year 2017
Number of shared co-authors 1
NYU Langone Health and NYU School of Medicine
Career Start Year 2016
Number of shared co-authors 2
Michael E DeBakey VA Medical Center
Career Start Year 2015
Number of shared co-authors 0
Department of Cardiovascular Medicine Mayo Clinic Rochester MN.
Career Start Year 2014
Number of shared co-authors 0
Yale University School of Medicine & Yale New Haven Hospital
Career Start Year 2013
Number of shared co-authors 2
9University of Michigan ann arbor
Career Start Year 2011
Number of shared co-authors 0
Division of Clinical Trials and Biostatistics, Mayo Clinic
Career Start Year 2011
Number of shared co-authors 10
Stanford University School of Medicine
Career Start Year 2010
Number of shared co-authors 2
David Geffen School of Medicine at university of california los angeles
Career Start Year 2009
Number of shared co-authors 0
Feinberg School of Medicine
Career Start Year 2009
Number of shared co-authors 0
Baylor College of Medicine
Career Start Year 2008
Number of shared co-authors 0
Cardiovascular Health Research Unit, University of Washington
Career Start Year 2008
Number of shared co-authors 3
Mayo Clinic
Career Start Year 2008
Number of shared co-authors 4
UT Southwestern Medical Center
Career Start Year 2006
Number of shared co-authors 5
University of Alabama at Birmingham
Career Start Year 2004
Number of shared co-authors 3
Duke University Medical Center
Career Start Year 2004
Number of shared co-authors 11
Rollins School of Public Health, Emory University
Career Start Year 2002
Number of shared co-authors 6
Rutgers University Institute for Health, the State University of New Jersey
Career Start Year 2001
Number of shared co-authors 3
Rocky Mountain Regional Veterans Affairs Medical Center Aurora CO USA.
Career Start Year 1999
Number of shared co-authors 2
University of California-San Francisco
Career Start Year 1998
Number of shared co-authors 4
Beth Israel Deaconess Medical Center
Career Start Year 1998
Number of shared co-authors 3
Wake Forest School of Medicine
Career Start Year 1997
Number of shared co-authors 1
Baylor College of Medicine
Career Start Year 1997
Number of shared co-authors 9
University of Florida
Career Start Year 1995
Number of shared co-authors 9
University of Washington
Career Start Year 1994
Number of shared co-authors 8
Michael E. DeBakey Veterans Affairs Medical Center, Baylor College of Medicine
Career Start Year 1993
Number of shared co-authors 0
and Blood Institute
Career Start Year 1991
Number of shared co-authors 4
Clinical Epidemiology Unit, Massachusetts General Hospital
Career Start Year 1978
Number of shared co-authors 4
Feinberg School of Medicine, Northwestern University
Career Start Year 1972
Number of shared co-authors 3
Kaiser Permanente Northern California
Career Start Year 1962
Number of shared co-authors 8

Collaborators

Duke Clinical Research Institute, Duke University
Co-authored papers 4
Duke University Medical Center
Co-authored papers 3
University of North Carolina
Co-authored papers 3
Pondicherry Institute of Medical Sciences
Co-authored papers 3
Duke University Medical Center
Co-authored papers 3
Co-authored papers 2
Co-authored papers 2
Penn Medicine Lancaster General Health Research Institute
Co-authored papers 2
Duke Molecular Physiology Institute, Duke University School of Medicine
Co-authored papers 2
University of Michigan ann arbor
Co-authored papers 2
Montreal Heart Institute, University of Montreal
Co-authored papers 1
Indiana University School of Medicine
Co-authored papers 1
Icahn School of Medicine at Mount Sinai
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
National Human Genome Research Institute
Co-authored papers 1
Montreal Heart Institute, Universite de Montreal
Co-authored papers 1
Institute for Health Equity Research, Icahn School of Medicine at Mount Sinai
Co-authored papers 1
Department of Pharmacotherapy and Translational Research, University of Florida
Co-authored papers 1
National Human Genome Research Institute, National Institutes of Health
Co-authored papers 1
Department of Pharmacotherapy and Translational Research, University of Florida
Co-authored papers 1
Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine
Co-authored papers 1
Weill Cornell Medical Center
Co-authored papers 1
Duke University
Co-authored papers 1
Mount Sinai Hospital, University of Toronto
Co-authored papers 1
Duke University School of Medicine
Co-authored papers 1
University of Texas Southwestern Medical Center
Co-authored papers 1
Johns Hopkins University School of Medicine
Co-authored papers 1
Northwestern University Feinberg School of Medicine
Co-authored papers 1
Duke Molecular Physiology Institute
Co-authored papers 1